Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06285214
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-02-22
Brief Title:
Study of V117957 in Interstitial CystitisBladder Pain Syndrome
Sponsor:
Imbrium Therapeutics
Organization:
Imbrium Therapeutics
Study Overview
Official Title:
Multicenter Randomized Double-blind Placebo-controlled Crossover Study to Investigate Effects of V117957 in Female Subjects With Interstitial CystitisBladder Pain Syndrome
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety tolerability and efficacy of V117957 in subjects with interstitial cystitisbladder pain syndrome compared to placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None